Surface modification of cobalt oxide nanoparticles using phosphonomethyl iminodiacetic acid followed by folic acid: A biocompatible vehicle for targeted anticancer drug delivery

Cancer Nanotechnology

Volumn 4, Issue 4-5, 2013, Pages 103-116

  Chattopadhyay, Sourav ^a   Dash, Sandeep Kumar ^a   Ghosh, Totan ^b   Das, Debasis ^b   Pramanik, Panchanan ^c   Roy, Somenath ^a  

^a VIDYASAGAR UNIVERSITY   (India)

^b UNIVERSITY OF CALCUTTA   (India)

^c INDIAN INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Cobalt oxide nanoparticles; Drug delivery; Flow cytometry; Folic acid; Uptake study

Indexed keywords

ACETIC ACID DERIVATIVE; ALDEHYDE; AMINE; CARBOXYL GROUP; COBALT OXIDE NANOPARTICLE; DOXORUBICIN; FOLATE RECEPTOR; FOLIC ACID; METAL OXIDE; METHOTREXATE; NANOPARTICLE; PHOSPHONOMETHYL IMINODIACETIC ACID; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; CANCER CELL CULTURE; CANCER THERAPY; CHEMICAL MODIFICATION; CONTROLLED STUDY; DISPERSION; DRUG CYTOTOXICITY; DRUG PROTEIN BINDING; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HYDRODYNAMICS; HYDROPHILICITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; INTERNALIZATION; LIGHT SCATTERING; PARTICLE SIZE; PH; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY;

EID: 84880826129     PISSN: 18686958     EISSN: 18686966     Source Type: Journal    
DOI: 10.1007/s12645-013-0042-7     Document Type: Article

References (37)

1. Antony AC (1996) Folate receptors. Annu Rev Nutr 16: 501-521. doi: 10. 1146/annurev. nu. 16. 070196. 002441.
2. Brunner TJ, Wick P, Manser P, Spohn P, Grass RN, Limbach LK, Bruinink A, Stark WJ (2006) In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ Sci Technol 40: 4374-4381. doi: 10. 1021/es052069i.
3. Chakraborty SP, Sahu SK, KarMahapatra S, Santra S, Bal M, Roy S, Pramanik P (2010) Nanoconjugate vancomycin: new opportunities for the development of anti-VRSA agents. Nanotechnology 21: 105103. doi: 10. 1088/0957-4484/21/10/105103.
4. Chattopadhyay S, Chakraborty SP, Laha D, Baral R, Pramanik P, Roy S (2012) Surface-modified cobalt oxide nanoparticles: new opportunities for anti-cancer drug development. Cancer Nano. doi: 10. 1007/s12645-012-0026-z.
5. Das M, Mishra D, Maiti TK, Basak A, Pramanik P (2008) Bio-functionalization of magnetite nanoparticles using an aminophosphonic acid coupling agent: new, ultradispersed, iron-oxide folate nanoconjugates for cancer-specific targeting. Nanotechnology 19: 415101. doi: 10. 1088/0957-4484/19/41/415101.
6. Decuzzi P, Ferrari M (2007) The role of specific and non-specific interactions in receptor-mediated endocytosis of nanoparticles. Biomaterials 28: 2915-2922.
7. Elnakat H, Ratnam M (2004) Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy. Adv Drug Deliv Rev 56: 1067-1084. doi: 10. 1016/j. addr. 2004. 01. 001.
8. Engin K, Leeper DB, Cater JR, Thistlethwaite AJ, Tupchong L, McFarlane JD (1995) Extracellular pH distribution in human tumors. Int J Hyperth 11: 211-216.
9. Faraji AH, Wipf P (2009) Nanoparticles in cellular drug delivery. Bioorg Med Chem 17: 2950-2962. doi: 10. 1016/j. bmc. 2009. 02. 043.
10. Ghosh T, Chattopadhyay T, Das S, Mondal S, Suresh E, Zangrando E, Das D (2011) Thiocyanate and dicyanamide anion controlled nuclearity in Mn, Co, Ni, Cu, and Zn metal complexes with hemilabile ligand 2-benzoylpyridine. Cryst Growth Des 11: 3198-3205. doi: 10. 1021/cg2004485.
11. Hudson L, Hay FC (1991) Practical immunology, 3rd ed. Blackwell, Oxford, pp 21-22.
12. Kamen BA, Capdevila A (1986) Receptor-mediated folate accumulation is regulated by the cellular folate content. Proc Natl Acad Sci 83: 5983-5987, PMCID: PMC386421.
13. Kamen BA, Smith AK (2004) A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro. Adv Drug Deliv Rev 56: 1085-1097. doi: 10. 1016/j. addr. 2004. 01. 002.
14. Leamon CP, Low PS (1991) Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis. Proc Natl Acad Sci 88: 5572-5576, PMCID: PMC51919.
15. Leamon CP, Reddy JA (2004) Folate-targeted chemotherapy. Adv Drug Deliv Rev 56: 1127-1141. doi: 10. 1016/j. addr. 2004. 01. 008.
16. Lee RJ, Low PS (1994) Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. JBC 269(5): 3198-3204.
17. Liong M, Lu J, Kovochich M, Xia T, Ruehm SG, Nel AE, Tamanoi F, Zink JI (2008) Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2: 889-896. doi: 10. 1021/nn800072t.
18. Low PS, Antony AC (2004) Folate receptor-targeted drugs for cancer and inflammatory diseases. Adv Drug Deliv Rev 56: 1057-1238. doi: 10. 1016/j. addr. 2004. 02. 003.
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, PMID: 14907713.
20. Maeda H, Bharate GY, Daruwalla J (2009) Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm 71: 409-419. doi: 10. 1016/j. ejpb. 2008. 11. 010.
21. Marin RV, Ng CH, Wilke M, Tiersch B, Fratzl P, Peter MG (2005) Size controlled hydroxyapatite nanoparticles as self-organized organic-inorganic composite materials. Biomaterials 26: 5414-5426. doi: 10. 1016/j. biomaterials. 2005. 01. 051.
22. Meiyanto E, Agustina D, Suparjan AM, Da' IM (2007) PVG-O induces apoptosis on T47D breast cancer cells line through caspase-3 activation. Jurnal Kedokteran Yarsi 15: 075-079.
23. Mellman I, Fuchs R, Helenius A (1986) Acidification of the endocytic and exocytic pathways. Annu Rev Biochem 55: 773-800.
24. Mohapatra S, Mallick SK, Maiti TK, Ghosh SK, Pramanik P (2007) Synthesis of highly stable folic acid conjugated magnetite nanoparticles for targeting cancer cells. Nanotechnology 18: 385102-385111. doi: 10. 1088/0957-4484/18/38/385102.
25. Mohapatra S, Rout SR, Maiti S, Maiti TK, Panda AB (2011) Monodisperse mesoporous cobalt ferrite nanoparticles: synthesis and application in targeted delivery of antitumor drugs. J Mater Chem 21: 9185. doi: 10. 1039/C1JM10732A.
26. Pan XQ, Zheng X, Shi G, Wang H, Ratnam H, Lee RJ (2002) A strategy for the treatment of acute myelogenous leukemia based on folate receptor type b-targeted liposomal doxorubicin in combined with receptor induction using all-trans retinoic acid. Blood 100: 594-602. doi: 10. 1182/blood. V100. 2. 594.
27. Panyam J, Labhasetwar V (2003) Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 55: 329-347. doi: 10. 1016/S0169-409X(02)00228-4.
28. Papis E, Rossi F, Raspanti M, Isabella DD, Colombo G, Milzani A, Bernardini G, Gornati R (2009) Engineered cobalt oxide nanoparticles readily enter cells. Toxicol Lett 189: 253-259. doi: 10. 1016/j. toxlet. 2009. 06. 851.
29. Park JS, Han TH, Lee KY, Han SS, Hwang JJ et al (2006) N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release. J Control Release 115: 37-45.
30. Patila S, Sandbergb A, Heckertc E, Self W, Seal S (2007) Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential. Biomaterials 28(31): 4600-4607. doi: 10. 1016/j. biomaterials. 2007. 07. 029.
31. Qu X, Cui S, Tian Z, Li X, Chen M, Xu FW, Inagaki Y, Deng BY, Makuuchi M, Nakata M, Tang W (2007) Induction of apoptosis in human hepatocellular carcinoma cells by synthetic antineoplaston A10. Anticancer Res 27: 2427-2432, PMID: 17695534.
32. Ribble D, Goldstein NB, Norris AD, Shellman YG (2005) A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol 5: 12. doi: 10. 1186/1472-6750-5-12.
33. Roa W, Xiaojing Z, Guo L, Shaw A, Hu X, Xiong Y, Gulavita S, Patel S, Sun X, Chen J, Moor R, Xing JZ (2009) Gold nanoparticles sensitize radiotherapy of prostate cancer cell by regulation of the cell cycle. Nanotechnology 20: 1-9. doi: 10. 1088/0957-4484/20/37/375101.
34. Sahu SK, Mallick SK, Santra S, Maiti TK, Ghosh SK, Pramanik P (2010) In vitro evaluation of folic acid modified carboxymethyl chitosan nanoparticles loaded with doxorubicin for targeted delivery. J Mater Sci Mater Med 21: 1587-1597. doi: 10. 1007/s10856-010-3998-4.
35. Uzun O, Hu Y, Verma A, Chen S, Centrone A, Stellacci F (2008) Water-soluble amphiphilic gold nanoparticles with structured ligand shells. Chem Commun 2: 196-198. doi: 10. 1039/b713143g.
36. van Sluis R, Bhujwalla ZM, Ballerteros P, Alverez J, Cerdan S, Galons JP et al (1999) In vivo imaging of extracellular pH using 1H MSRI. Magn Reson Med 41: 743-750.
37. Wang K, Xu JJ, Chen HY (2005) A novel glucose biosensor based on the nanoscaled cobalt phthalocyanine-glucose oxidase biocomposite. Biosens Bioelectron 20: 1388-1396. doi: 10. 1016/j. bios. 2004. 06. 006.